학술논문
Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak
Document Type
Article
Author
Source
In Clinical Breast Cancer October 2022
Subject
Language
ISSN
1526-8209